1-(4-bromophenyl)-3,5-dimethyl-1h-pyrazole; 97%; 1g; F.W.: 251.12; C11H11BrN2; Primary CAS: 62546-27-4
-
P/N:
CC68210DA
- UOM: EA
- UOM Qty: 1
|
|
1-(4-bromophenyl)-3,5-dimethyl-1h-pyrazole; 97%; 250mg; F.W.: 251.12; C11H11BrN2; Primary CAS: 62546-27-4
-
P/N:
CC68210CB
- UOM: EA
- UOM Qty: 1
|
|
[4-(3,5-dimethyl-1h-pyrazol-1-yl)phenyl]methanol; 97%; 1g; F.W.: 202.25; C12H14N2O; M.P.: 57-58.5; Primary CAS: 934570-55-5
-
P/N:
CC68209DA
- UOM: EA
- UOM Qty: 1
|
|
4-(3,5-dimethyl-1h-pyrazol-1-yl)benzaldehyde; 97%; 1g; F.W.: 200.24; C12H12N2O; M.P.: 78-80.5; Primary CAS: 934570-54-4
-
P/N:
CC68204DA
- UOM: EA
- UOM Qty: 1
|
|
tert-butyl 4-(4-bromobenzyloxy)piperidine-1-carboxylate; 5g; Primary CAS:
-
P/N:
CC67910DE
- UOM: EA
- UOM Qty: 1
|
|
tert-butyl 4-(4-bromobenzyloxy)piperidine-1-carboxylate; 1g; Primary CAS:
-
P/N:
CC67910DA
- UOM: EA
- UOM Qty: 1
|
|
4-(3-Bromothien-2-yl)-N-methylbenzylamine; 97%; 5g; F.W.: 282.19; C12H12BrNS; B.P.: 132-134 (0.15002mmHg); Primary CAS: 937796-02-6
-
P/N:
CC67846DE
- UOM: EA
- UOM Qty: 1
|
|
4-(3-Bromothien-2-yl)-N-methylbenzylamine; 97%; 1g; F.W.: 282.19; C12H12BrNS; B.P.: 132-134 (0.15002mmHg); Primary CAS: 937796-02-6
-
P/N:
CC67846DA
- UOM: EA
- UOM Qty: 1
|
|
1-[4-(3-bromothien-2-yl)phenyl]ethanone; 97%; 5g; F.W.: 281.16; C12H9BrOS; M.P.: 71.5-73; Primary CAS: 937796-01-5
-
P/N:
CC67828DE
- UOM: EA
- UOM Qty: 1
|
|
1-[4-(3-bromothien-2-yl)phenyl]ethanone; 97%; 1g; F.W.: 281.16; C12H9BrOS; M.P.: 71.5-73; Primary CAS: 937796-01-5
-
P/N:
CC67828DA
- UOM: EA
- UOM Qty: 1
|
|
